本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Redhill Biopharma Ltd

1.17
-0.0370-3.07%
盤後1.16-0.0080-0.68%17:27 EST
成交量:3.47萬
成交額:4.17萬
市值:388.93萬
市盈率:-0.19
高:1.24
開:1.22
低:1.16
收:1.21
52周最高:7.30
52周最低:1.01
股本:332.99萬
流通股本:307.58萬
量比:0.44
換手率:1.13%
股息:- -
股息率:- -
每股收益(TTM):-6.0249
每股收益(LYR):-6.7096
淨資產收益率:-1708.61%
總資產收益率:-25.32%
市淨率:-0.88
市盈率(LYR):-0.17

資料載入中...

2025/06/30

SEC問詢函

Form CORRESP - Correspondence
2025/06/25

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2025/04/10

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2025/03/26

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/11/14

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/16

SEC問詢函

Form CORRESP - Correspondence
2024/06/20

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/04/08

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/15

SEC問詢函

Form CORRESP - Correspondence
2024/02/09

招股説明書

Form F-1 - Registration statement for certain foreign private issuers
2024/02/02

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/08

超過5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/10/26

SEC問詢函

Form CORRESP - Correspondence
2023/08/10

SEC問詢函

Form CORRESP - Correspondence
2023/06/29

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/04/28

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/01/13

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/06/27

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/17

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]